LOOK DIFFERENTLY.

For women with dense breasts. Personalized screening. Everywhere.

Mobile Invenia™ ABUS 2.0 can help you improve access to personalized breast care with a focus on screening dense breasts.
At a Glance

Small cancer – big impact

ABUS helps to find small cancers in dense breasts for early treatment

Grow your investment

Improve access to personalized care for women with dense breasts even in rural regions

Enhance patient comfort

100% of women1 would recommend non-invasive ABUS to their best friend
EXPAND YOUR REACH

Bring the power of ABUS to your patients

Patient-friendly Invenia ABUS 2.0 is the first FDA-approved ultrasound supplemental screening technology that is specifically designed for detecting cancer in dense breast tissue.
THE CHALLENGE

Dense breasts and the ABUS solution

Over 40 percent of women have dense breast tissue,2 one of the most common risk factors for developing breast cancer.3 In dense breasts, cancers may be masked on mammography – potentially delaying diagnosis in these women.4,5

Supplemental imaging with Invenia ABUS 2.0 transforms breast care from reactive to proactive. Clinical research studies have demonstrated that when used as an adjunct to mammography, small cancers visible only through ABUS were predominantly invasive and node-negative.6,7

And now, a mobile solution allows you to bring this extraordinary patient care to more places.
SHARE A SYSTEM

See additional patients by sharing your system between several clinic locations

Your Invenia ABUS 2.0 system can be transported to multiple facilities via truck or van using the Mobile ABUS Fixation Bracket*. This allows your facility to enhance its asset utilization and ROI and discover incremental revenue stream potential.

Our custom ride-suspension system protects delicate electronics against over-the-road vibrations, ensuring your asset arrives at its destination in the same condition it left.
MOBILE MEDICAL UNIT

Improve access to personalized care with a mobile screening coach

Consider a dedicated mobile Invenia ABUS solution to help offer standardized, user-independent and reproducible ABUS exams to a larger patient population.

Clinical interpretation can smoothly integrate into your current workflow.
REFERENCES
  1. 1. Shah et.al. Journal of Diagnostic Medical Sonography DOI: 10.1177/8756479313476920 2013.
  2. 2. Pisano et al. NEJM 2005; 353: 1773.
  3. 3. Engmann NJ, et al, JAMA Oncol. 2017;3(9):1228-1236.
  4. 4. Mandelson et al. J Natl Cancer Inst 2000; 92:1081-1087.
  5. 5. Tagliafico, Massimo Calabrese et al, Journal of Clinical Oncology 2016 34:16, 1882-1888.
  6. 6. FDA PMA P110006 summary of safety and effectiveness.
  7. 7. Wilczek B, European Journal of Radiology (DOI: 10.1016/j.ejrad.2016. 06.004).

    8. *The Invenia ABUS 2.0 device is not designed for use in a mobile environment unless it is installed using the Mobile ABUS fixation system.

Have a question? We would love to hear from you.

JB21487XX